Taking stock of the present and looking ahead: envisioning challenges in the design of future HIV prevention efficacy trials-Reference-Cited by-同舟云学术

Taking stock of the present and looking ahead: envisioning challenges in the design of future HIV prevention efficacy trials

Published:2019-07 Issue:7 Volume:6 Page:e475-e482
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Janes Holly,Donnell Deborah,Gilbert Peter B,Brown Elizabeth R,Nason Martha

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference40 articles.

1. Behavioral and biomedical combination strategies for HIV prevention;Bekker;Cold Spring Harb Perspect Med,2012

2. A sequential phase 2b trial design for evaluating vaccine efficacy and immune correlates for multiple hiv vaccine regimens;Gilbert;Stat Commun Infect Dis,2011

3. Basis and statistical design of the passive HIV-1 antibody mediated prevention (AMP) test-of-concept efficacy trials;Gilbert;Stat Commun Infect Dis,2017

4. Ethical considerations regarding oral preexposure prophylaxis in HIV prevention trials;Sugarman;Curr Opin HIV AIDS,2016

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human Immunodeficiency Virus Vaccine;Infectious Disease Clinics of North America;2024-09

2. Human T-lymphotropic virus type 1 and antiretroviral therapy: practical considerations for pre-exposure and post-exposure prophylaxis, transmission prevention, and mitigation of severe disease;The Lancet Microbe;2024-04

3. Control groups for HIV prevention efficacy trials: what does the future hold?;Current Opinion in HIV and AIDS;2023-09-11

4. Key stakeholders’ perspectives on providing oral pre-exposure prophylaxis as HIV-prevention standard of care in clinical trials in South Africa;African Journal of AIDS Research;2023-01-02

5. Testing for treatment effect twice using internal and external controls in clinical trials;Journal of Causal Inference;2023-01-01